Stanford Cancer Institute

The Stanford Cancer Institute is an NCI-designated Cancer Center at Stanford University in Palo Alto, CA. It is one of eight comprehensive cancer centers in California.

The Stanford Cancer Institute leverages the scientific, technological, and human resources of Stanford University and Stanford Health Care to enhance the understanding of cancer. It facilitates the translation of research discoveries into improved prevention strategies, diagnostic methods, and more effective and safer therapies.

The Stanford Cancer Institute has more than 300 faculty members within the Stanford network. Adult patients are treated at the Stanford Cancer Center.

History
The Stanford Cancer Institute was founded in 2004 and first received NCI-designation as a clinical cancer center in 2007. In 2016, it received its comprehensive cancer center designation. In 2022, the Stanford Cancer Institute received its comprehensive cancer center designation renewal.

Stanford University was a founding member of the National Comprehensive Cancer Network in 1995.

In 2016, a new center was created as part of the Parker Institute for Cancer Immunotherapy. Stanford received $10 million from the Parker Foundation. This is a $250 million joint venture with five other cancer centers across the country.

In 2017, a donation by Jeffrey Rothschild established the Stanford Center for Cancer Cell Therapy, which supports research into the development of immunological based treatments for cancer.

Timeline

 * 2004: The Stanford Cancer Institute is founded to advance the understanding of cancer through a multidisciplinary, integrated, and collaborative community of physicians and scientists. Irving Weissman serves as the Institute’s inaugural director.
 * 2007: The Stanford Cancer Institute receives its initial National Cancer Institute Cancer Center designation.
 * 2008: Beverly Mitchel is named as director of the Stanford Cancer Institute. She replaces outgoing director Weissman.
 * 2013: Stanford Cancer Institute Innovation Awards is founded to support Stanford cancer projects that hold significant promise in innovating cancer science and treatment.
 * 2016: The Stanford Cancer Institute receives its National Cancer Institute Comprehensive Cancer Center designation.
 * 2018: Steve Artandi is named as director of the Stanford Cancer Institute. He replaces outgoing director Mitchell.
 * 2022: The Stanford Cancer Institute receives its National Cancer Institute Comprehensive Cancer Center designation renewal.